Progressive supranuclear palsy

被引：0
|
作者：
Bartosova, T. [1 ]
Klempir, J. [1 ,2 ,3 ]
机构：
[1] 1 LF UK VFN Praze, Neurol Klin, Ctr Klin Kych Neuroved, Katerinska 30, Prague 12000, Czech Republic
[2] 1 LF UK VFN Praze, Anat Ostav, Prague 12000, Czech Republic
[3] Evropska Referentni Sit Pro Vzacna Neurol, Prague, Czech Republic
来源：
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | 2020年 / 83卷 / 06期
关键词：
progressive supranuclear palsy; vertical gaze palsy; tauopathy; postural instability; parkinsonism; cognitive decline; levodopa; amantadine; FRONTOTEMPORAL LOBAR DEGENERATION; MAGNETIC-RESONANCE PARKINSONISM; RICHARDSON-OLSZEWSKI SYNDROME; SLEEP BEHAVIOR DISORDER; CORTICOBASAL DEGENERATION; DIFFERENTIAL-DIAGNOSIS; PHENOTYPIC SPECTRUM; DEMENTIA COMPLEX; SPINAL-CORD; TAU;
D O I：
10.48095/cccsnn2020584
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Progressive supranuclear palsy is a tauopathy belonging to atypical Parkinsonian syndromes. The main clinical symptoms include oculomotor dysfunctions, early postural instability, symmetrical hypokinetic-rigid syndrome with axial predominance and cognitive decline. The symptom variability and rate of progression depend on disease subtype. Diagnostics are based on clinical symptoms; MRI remains the most useful auxiliary method. The article is focused mainly on clinical perspectives and recent diagnostic approaches considering the latest recommendations. Symptomatic therapy remains of great importance as causal treatment is still lacking.
引用
收藏
页码：584 / 601
页数：18
相关论文
共 50 条
  • [41] Progressive Supranuclear Palsy: an Update
    Armstrong, Melissa J.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (03)
  • [42] Photophobia and Progressive Supranuclear Palsy
    Hay, K.
    Mohanty, D.
    Lin, Y.
    Kang, H.
    Sellers-Gibson, J.
    Claassen, D.
    MOVEMENT DISORDERS, 2020, 35 : S504 - S504
  • [43] VASCULAR PROGRESSIVE SUPRANUCLEAR PALSY
    WINIKATES, J
    JANKOVIC, J
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1994, (42): : 189 - 201
  • [44] Dysphagia in Progressive Supranuclear Palsy
    Clark, Heather M.
    Stierwalt, Julie A. G.
    Tosakulwong, Nirubol
    Botha, Hugo
    Ali, Farwa
    Whitwell, Jennifer L.
    Josephs, Keith A.
    DYSPHAGIA, 2020, 35 (04) : 667 - 676
  • [45] Progressive supranuclear palsy revisited
    Litvan, I
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 98 (02): : 73 - 84
  • [46] Progressive Supranuclear Palsy: an Update
    Melissa J. Armstrong
    Current Neurology and Neuroscience Reports, 2018, 18
  • [47] Immunotherapy in progressive supranuclear palsy
    Vaswani, Pavan A.
    Olsen, Abby L.
    CURRENT OPINION IN NEUROLOGY, 2020, 33 (04) : 527 - 533
  • [48] PALILALIA IN PROGRESSIVE SUPRANUCLEAR PALSY
    ZINGESER, L
    LUX, W
    LORR, J
    BROWN, J
    NEUROLOGY, 1986, 36 (04) : 344 - 345
  • [49] Caregiving in progressive supranuclear palsy
    Uttl, B
    Santacruz, P
    Litvan, I
    Grafman, J
    NEUROLOGY, 1998, 51 (05) : 1303 - 1309
  • [50] Hypertension and progressive supranuclear palsy
    Rabadia, Soniya V.
    Litvan, Irene
    Juncos, Jorge
    Bordelon, Yvette
    Riley, David E.
    Standaert, David
    Reich, Stephen G.
    Hall, Deborah A.
    Kluger, Benzi
    Shprecher, David
    Marras, Connie
    Jankovic, Joseph
    Dubinsky, Richard
    Henchcliffe, Claire
    Uitti, Ryan
    Leverenz, James
    PARKINSONISM & RELATED DISORDERS, 2019, 66 : 166 - 170
12345